Clinical Trials

NCT03065686 | RECRUITING | NA

30 participants

Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2016-11-30
Completion:: 2027-11-30

Conditions

Cleft Lip and Palate

Interventions

GENETIC

No Results Yet

NCT03047213 | ACTIVE_NOT_RECRUITING | PHASE2

17 participants

Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2017-08-24
Completion:: 2020-10-06

Conditions

Locally Advanced Bladder Urothelial Carcinoma
Metastatic Transitional Cell Carcinoma
Metastatic Urothelial Carcinoma
Recurrent Bladder Carcinoma
Stage III Bladder Urothelial Carcinoma AJCC v6 and v7
Stage IV Bladder Urothelial Carcinoma AJCC v7

Interventions

DRUG

Results Available

NCT03041688 | ACTIVE_NOT_RECRUITING | PHASE1

58 participants

Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2018-02-08
Completion:: 2026-06-30

Conditions

Acute Myeloid Leukemia
Recurrent Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
Secondary Acute Myeloid Leukemia

Interventions

PROCEDURE
DRUG

No Results Yet

NCT03033446 | COMPLETED | PHASE2

40 participants

Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2016-12-20
Completion:: 2019-08-31

Conditions

HepatoCellular Carcinoma

Interventions

RADIATION
DRUG

No Results Yet

NCT03017326 | ACTIVE_NOT_RECRUITING | PHASE3

450 participants

Paediatric Hepatic International Tumour Trial

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2017-08-24
Completion:: 2026-12-31

Conditions

Hepatoblastoma
Carcinoma, Hepatocellular

Interventions

DRUG

No Results Yet

NCT02997228 | ACTIVE_NOT_RECRUITING | PHASE3

120 participants

Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2018-01-19
Completion:: 2027-06-01

Conditions

Metastatic Colorectal Adenocarcinoma
Stage IV Colorectal Cancer AJCC v7

Interventions

DRUG
BIOLOGICAL
PROCEDURE
OTHER

No Results Yet

NCT02978625 | ACTIVE_NOT_RECRUITING | PHASE2

68 participants

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2017-09-27
Completion:: 2027-09-01

Conditions

Anaplastic Large Cell Lymphoma, ALK-Negative
Anaplastic Large Cell Lymphoma, ALK-Positive
Apocrine Carcinoma
Carcinoma Arising From Cylindroma
Carcinoma Arising From Spiradenoma
Digital Papillary Adenocarcinoma
Endocrine Mucin-Producing Sweat Gland Carcinoma
Extramammary Paget Disease
Extraocular Sebaceous Carcinoma
Hidradenocarcinoma
Malignant Sweat Gland Neoplasm
Merkel Cell Carcinoma
Microcystic Adnexal Carcinoma
NK-Cell Lymphoma, Unclassifiable
Papillary Adenocarcinoma
Porocarcinoma
Primary Cutaneous Mucinous Carcinoma
Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Recurrent T-Cell Non-Hodgkin Lymphoma
Refractory Anaplastic Large Cell Lymphoma
Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Refractory Merkel Cell Carcinoma
Refractory Mycosis Fungoides
Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Refractory Skin Squamous Cell Carcinoma
Refractory T-Cell Non-Hodgkin Lymphoma
Sezary Syndrome
Signet Ring Cell Adenocarcinoma
Skin Adenoid Cystic Carcinoma
Skin Adnexal Carcinoma
Skin Basal Cell Carcinoma
Skin Basosquamous Cell Carcinoma
Skin Keratoacanthoma
Skin Squamous Cell Carcinoma
Squamoid Eccrine Ductal Carcinoma
Squamous Cell Carcinoma of Unknown Primary
Sweat Gland Carcinoma
Trichilemmal Carcinoma
Vulvar Squamous Cell Carcinoma

Interventions

PROCEDURE
OTHER
BIOLOGICAL

No Results Yet

NCT02929849 | COMPLETED | NA

51 participants

Satiety and Glucose Indices in Adults

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2015-08-31
Completion:: 2016-06-30

Conditions

Obesity

Interventions

DIETARY_SUPPLEMENT

No Results Yet

NCT02923778 | ACTIVE_NOT_RECRUITING | PHASE2

40 participants

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2019-12-31
Completion:: 2026-12-29

Conditions

Leiomyosarcoma
Liposarcoma
Sarcoma G2
Sarcoma G3
Soft Tissue Sarcoma
Soft Tissue Sarcoma of the Trunk and Extremities
Stage I Soft Tissue Sarcoma AJCC v7
Stage II Soft Tissue Sarcoma AJCC v7
Undifferentiated Pleomorphic Sarcoma

Interventions

PROCEDURE
RADIATION
BIOLOGICAL

No Results Yet

NCT02862275 | ACTIVE_NOT_RECRUITING | PHASE1

40 participants

Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2017-05-24
Completion:: 2026-11-21

Conditions

Hematopoietic and Lymphoid Cell Neoplasm
Metastatic Malignant Solid Neoplasm
Unresectable Malignant Solid Neoplasm

Interventions

DRUG
PROCEDURE
OTHER

No Results Yet

NCT02852538 | COMPLETED | NA

93 participants

Outcomes of a Skill-Based Program for Eating Disorders

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2015-02-28
Completion:: 2026-05-08

Conditions

Anorexia Nervosa

Interventions

BEHAVIORAL

No Results Yet

NCT02841748 | COMPLETED | PHASE2

100 participants

A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2017-05-10
Completion:: 2025-02-11

Conditions

Head and Neck Cancer
Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG

Results Available

NCT02829190 | RECRUITING | PHASE3

80 participants

Feasibility Study of Phase-contrast MRI for Flow in the External Carotid Branches Arteries

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2014-01-06
Completion:: 2027-12-31

Conditions

Carotid Artery, External

Interventions

DEVICE

No Results Yet

NCT02818400 | RECRUITING | NA

5 participants

Composite Tissue Allotransplantation of the Face: Anatomical and Functional Evaluation

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2009-11-30
Completion:: 2026-12-31

Conditions

Surgery, Oral

Interventions

PROCEDURE

No Results Yet

NCT02815891 | COMPLETED

7330 participants

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-13
Start Date:: 2016-07-31
Completion:: 2026-05-31

Conditions

Nonalcoholic Fatty Liver
Nonalcoholic Steatohepatitis

No Results Yet

NCT02806388 | RECRUITING

5500 participants

Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-13
Start Date:: 2011-10-31
Completion:: 2026-12-31

Conditions

Solid Tumor

No Results Yet

NCT02797795 | COMPLETED | PHASE1

78 participants

A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2016-12-31
Completion:: 2023-12-31

Conditions

Advanced Cancer
Solid Tumors

Interventions

DRUG

No Results Yet

NCT02737566 | COMPLETED | NA

320 participants

Small Financial Incentives to Promote Smoking Cessation

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2017-01-30
Completion:: 2022-02-08

Conditions

Smoking Cessation

Interventions

BEHAVIORAL
OTHER

Results Available

NCT02629692 | TERMINATED | PHASE1/PHASE2

124 participants

Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2016-06-27
Completion:: 2025-01-03

Conditions

Healthy (For Part A)
Chronic Myeloid Leukemia (for Part B and C)

Interventions

DRUG

Results Available

NCT02595931 | ACTIVE_NOT_RECRUITING | PHASE1

66 participants

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2016-07-22
Completion:: 2023-03-07

Conditions

Metastatic Colorectal Carcinoma
Metastatic Lung Small Cell Carcinoma
Metastatic Malignant Solid Neoplasm
Metastatic Pancreatic Carcinoma
Refractory Colorectal Carcinoma
Refractory Lung Small Cell Carcinoma
Refractory Malignant Solid Neoplasm
Refractory Pancreatic Carcinoma
Stage III Colorectal Cancer AJCC v8
Stage III Lung Cancer AJCC v8
Stage III Pancreatic Cancer AJCC v8
Stage IV Colorectal Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Stage IV Pancreatic Cancer AJCC v8
Unresectable Colorectal Carcinoma
Unresectable Lung Small Cell Carcinoma
Unresectable Malignant Solid Neoplasm
Unresectable Pancreatic Carcinoma

Interventions

DRUG
PROCEDURE

No Results Yet

NCT02534038 | TERMINATED | PHASE2

1 participants

Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2015-12-01
Completion:: 2017-10-03

Conditions

Disinhibition Syndrome

Interventions

DRUG

Results Available

NCT02496663 | ACTIVE_NOT_RECRUITING | PHASE1

138 participants

Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2016-05-11
Completion:: 2027-06-30

Conditions

Metastatic Lung Non-Small Cell Carcinoma
Recurrent Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8

Interventions

PROCEDURE
BIOLOGICAL
DRUG

No Results Yet

NCT02496208 | ACTIVE_NOT_RECRUITING | PHASE1

152 participants

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2015-07-22
Completion:: 2026-09-30

Conditions

Bladder Small Cell Neuroendocrine Carcinoma
Bladder Squamous Cell Carcinoma
Bladder Urothelial Carcinoma
Clear Cell Renal Cell Carcinoma
Invasive Bladder Plasmacytoid Urothelial Carcinoma
Invasive Bladder Sarcomatoid Urothelial Carcinoma
Invasive Sarcomatoid Urothelial Carcinoma
Kidney Medullary Carcinoma
Malignant Genitourinary System Neoplasm
Malignant Solid Neoplasm
Penile Carcinoma
Penile Squamous Cell Carcinoma
Renal Cell Carcinoma
Renal Pelvis Urothelial Carcinoma
Sarcomatoid Renal Cell Carcinoma
Stage III Bladder Cancer AJCC v8
Stage III Penile Cancer AJCC v8
Stage III Renal Cell Cancer AJCC v8
Stage III Renal Pelvis and Ureter Cancer AJCC v8
Stage III Renal Pelvis Cancer AJCC v8
Stage III Ureter Cancer AJCC v8
Stage III Urethral Cancer AJCC v8
Stage IV Bladder Cancer AJCC v8
Stage IV Penile Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8
Stage IV Renal Pelvis and Ureter Cancer AJCC v8
Stage IV Ureter Cancer AJCC v8
Stage IV Urethral Cancer AJCC v8
Ureter Urothelial Carcinoma
Urethral Urothelial Carcinoma

Interventions

PROCEDURE
DRUG
BIOLOGICAL

No Results Yet

NCT02477670 | COMPLETED | PHASE2

145 participants

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2015-09-01
Completion:: 2017-07-21

Conditions

Schizophrenia

Interventions

DRUG

Results Available

NCT02425345 | COMPLETED | NA

49331 participants

Women's Health Initiative Strong and Healthy Study

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2015-04-02
Completion:: 2024-12-31

Conditions

Myocardial Infarction
Stroke
Cardiovascular Mortality
Hip Fractures
Falls
Mortality
Venous Thromboembolic Event
Peripheral Artery Disease
Physical Function
Coronary Revascularization
Mobility and Independence
Clinical (Non-hip) Fractures
Sleep
Depressive Symptoms

Interventions

BEHAVIORAL

Results Available

NCT02380716 | COMPLETED

21 participants

ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2015-08-31
Completion:: 2021-02-26

Conditions

Aortic Dissection

Interventions

DEVICE

Results Available

NCT02362035 | COMPLETED | PHASE1/PHASE2

161 participants

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2015-02-20
Completion:: 2020-07-14

Conditions

Follicular Lymphoma (FL)
CLL
Small Lymphocytic Lymphoma (SLL)
Richter's Syndrome
Mantle Cell Lymphoma (MCL)
Indolent Non Hodgkin Lymphoma
Waldenström Macroglobulinemia
Multiple Myeloma
Hodgkin Lymphoma
Burkitt Lymphoma
Marginal Zone Lymphomas
Mediastinal Large B Cell Lymphoma
Hairy Cell Leukemia

Interventions

DRUG

Results Available

NCT02359565 | ACTIVE_NOT_RECRUITING | PHASE1

71 participants

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2015-06-03
Completion:: 2026-01-05

Conditions

Constitutional Mismatch Repair Deficiency Syndrome
Lynch Syndrome
Malignant Glioma
Recurrent Brain Neoplasm
Recurrent Childhood Ependymoma
Recurrent Diffuse Intrinsic Pontine Glioma
Recurrent Medulloblastoma
Refractory Brain Neoplasm
Refractory Diffuse Intrinsic Pontine Glioma
Refractory Ependymoma
Refractory Medulloblastoma

Interventions

PROCEDURE
BIOLOGICAL

No Results Yet

NCT02337283 | COMPLETED | PHASE1

96 participants

Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2015-01-15
Completion:: 2015-11-16

Conditions

Healthy

Interventions

DRUG

Results Available

NCT02298959 | ACTIVE_NOT_RECRUITING | PHASE1

59 participants

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2015-04-08
Completion:: 2025-05-21

Conditions

Clinical Stage IV Cutaneous Melanoma AJCC v8
Metastatic Colorectal Carcinoma
Metastatic Malignant Solid Neoplasm
Metastatic Melanoma
Metastatic Ovarian Carcinoma
Metastatic Renal Cell Carcinoma
Platinum-Resistant Ovarian Carcinoma
Recurrent Melanoma
Recurrent Renal Cell Carcinoma
Refractory Melanoma
Refractory Renal Cell Carcinoma
Sarcoma
Stage IV Colorectal Cancer AJCC v8
Stage IV Ovarian Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8

Interventions

PROCEDURE
BIOLOGICAL

No Results Yet

NCT02250352 | RECRUITING

400 participants

Core Biopsies for Establishing a Breast Tumor Tissue Repository

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-13
Start Date:: 2013-11-14
Completion:: 2026-11-14

Conditions

Breast Cancer

Interventions

OTHER

No Results Yet

NCT02172651 | RECRUITING | EARLY_PHASE1

80 participants

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2014-07-14
Completion:: 2027-04-15

Conditions

Stage, Colon Cancer
Stage I-III Colon Cancer
Stage IV Colon Cancer With Resectable Liver Metastases

Interventions

DRUG

No Results Yet

NCT02160015 | ACTIVE_NOT_RECRUITING | PHASE1

12 participants

Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2014-05-20
Completion:: 2017-03-27

Conditions

Recurrent Chronic Lymphocytic Leukemia
Recurrent Small Lymphocytic Lymphoma
Refractory Chronic Lymphocytic Leukemia
Refractory Small Lymphocytic Lymphoma

Interventions

PROCEDURE
DRUG
BIOLOGICAL

No Results Yet

NCT02133196 | RECRUITING | PHASE2

85 participants

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2014-10-23
Completion:: 2027-10-23

Conditions

Advanced Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Advanced NSCLC
Adenosquamous Carcinoma
Adenocarcinoma

Interventions

DRUG
BIOLOGICAL

No Results Yet

NCT02132741 | RECRUITING

150 participants

Optical Coherence Tomography And NEphropathy: The OCTANE Study

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-13
Start Date:: 2014-05-16
Completion:: 2027-12-31

Conditions

Health
Hypertension
Chronic Kidney Disease

No Results Yet

NCT02042326 | RECRUITING | PHASE2

50 participants

Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2014-09-12
Completion:: 2027-09-30

Conditions

Arteriovenous Malformations

Interventions

DRUG

No Results Yet

NCT01989585 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

75 participants

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2014-03-24
Completion:: 2027-12-31

Conditions

Clinical Stage III Cutaneous Melanoma AJCC v8
Clinical Stage IV Cutaneous Melanoma AJCC v8
Malignant Solid Neoplasm
Metastatic Melanoma
Unresectable Melanoma

Interventions

PROCEDURE
DRUG
OTHER
BIOLOGICAL

No Results Yet

NCT01955499 | ACTIVE_NOT_RECRUITING | PHASE1

39 participants

Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2013-09-24
Completion:: 2024-11-06

Conditions

Recurrent Diffuse Large B-Cell Lymphoma
Recurrent Follicular Lymphoma
Recurrent Lymphoplasmacytic Lymphoma
Recurrent Mantle Cell Lymphoma
Recurrent Marginal Zone Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
Refractory Follicular Lymphoma
Refractory Lymphoplasmacytic Lymphoma
Refractory Mantle Cell Lymphoma
Refractory Marginal Zone Lymphoma

Interventions

PROCEDURE
DRUG

No Results Yet

NCT01893554 | COMPLETED | PHASE1

88 participants

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children

Study Type:: INTERVENTIONAL
Last Updated:: 2026-05-13
Start Date:: 2013-06-01
Completion:: 2023-04-26

Conditions

Respiratory Syncytial Virus Infections

Interventions

BIOLOGICAL

No Results Yet

NCT01875588 | RECRUITING

1150 participants

Thinking and Memory Problems in People With HIV

Study Type:: OBSERVATIONAL
Last Updated:: 2026-05-13
Start Date:: 2013-07-08
Completion:: 2037-02-22

Conditions

HIV Positive

No Results Yet